ATC Group: V09IB01 Indium (111In) pentetreotide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09IB01 in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09I Tumour detection
4 V09IB Indium (111In) compounds
5 V09IB01 Indium (111In) pentetreotide

Active ingredients in V09IB01

Active Ingredient Description
Indium ¹¹¹In pentetreotide

Indium(111In)pentetreotide specifically binds to receptors for somatostatin. After radiolabelling pentetreotide with indium( 111In)chloride, the solution obtained is indicated for use as adjunct in the diagnosis and management of receptor bearing gastro-entero-pancreatic neuroendocrine (GEP) tumours and carcinoid tumours, by aiding in their localisation.

Related product monographs

Title Information Source Document Type  
OCTREOSCAN Kit for radiopharmaceutical preparation Health Products Regulatory Authority (IE) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

France (FR)

Ireland (IE)

Japan (JP)

Singapore (SG)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.